Industry
Sinha diary: Bhushan tells SC he won’t disclose source
18 Sep 2014
Lawyer Prashant Bhushan, who has filed a public interest suit against CBI director Ranjit Sinha, today refused a Supreme Court directive to reveal the name of the whistleblower who provided him with Sinha’s residential guest book
TV still leads India’s entertainment & media industry, but internet growth faster
17 Sep 2014
Internet access and internet advertising have been the fastest-growing segments, with annual growth rates of 47 per cent and 26 per cent respectively.
TV still leads India’s entertainment & media industry, but internet growth faster
17 Sep 2014
Internet access and internet advertising have been the fastest-growing segments, with annual growth rates of 47 per cent and 26 per cent respectively.
TUI Travel to merge with parent to create £5.2-bn tourism giant
16 Sep 2014
The merger would see TUI Travel, which serves 30 million customers join TUI AG, owner of 230 hotels and seven cruise ships
Real estate transactions go online
15 Sep 2014
In the last couple of years, real estate sector has seen the emergence of websites as a low-cost tool to connect buyers and sellers. By Advitiya Sharma, co-founder and marketing head, housing.com
Reveal source of ‘Sinha diaries’, SC tells Prashant Bhushan
15 Sep 2014
CBI director Ranjit Sinha has consistently maintained that the log of visitors at his residence provided by activist Supreme Court lawyer Prashant Bhushan to the SC is a forgery, with 90 per cent of the entries forged
US judge upholds Ranbaxy-Pfizer Lipitor marketing deal
13 Sep 2014
In a piece of good news for the US FDA-challenged Ranbaxy laboratories, a US court has dismissed an anti-trust suit against Pfizer Inc and India's Ranbaxy that accused them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor
US judge upholds Ranbaxy-Pfizer Lipitor marketing deal
13 Sep 2014
In a piece of good news for the US FDA-challenged Ranbaxy laboratories, a US court has dismissed an anti-trust suit against Pfizer Inc and India's Ranbaxy that accused them of conspiring to delay sales of generic versions of the cholesterol drug Lipitor
Coalgate: SC refuses to reopen hearing for power companies
12 Sep 2014
With the centre advocating cancellation of the coal blocks awarded illegally, companies have blamed the government for irregularities and demanded the setting up of a committee to go into each of the allocations